FdaApplication

ANDA 211436

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTEVA PHARMACEUTICALS USA INC
application_typeANDA
approval_date2020-08-03

Products (1)

ProductActive ingredientStrengthDosage form
MIFEPRISTONEMIFEPRISTONE300MGTABLET;ORAL

1 product